Guanidine and amidine derivatives as factor Xa inhibitors

Details Guanidine and amidine derivatives as factor Xa inhibitors Guanidine and amidine derivatives as factor Xa inhibitors

2004-07-07

2008-10-14

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S326000, C514S364000, C546S209000, C546S229000, C548S131000, C564S225000

Reexamination Certificate

active

07435747

ABSTRACT:
The present invention relates to compounds of the formula I,in which R0; Q; X; Q′, D, R10and V have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.

REFERENCES:
patent: 5260307 (1993-11-01), Ackermann et al.
patent: 5792769 (1998-08-01), Lu et al.
patent: 6277865 (2001-08-01), Klein
patent: 6417200 (2002-07-01), Beight et al.
patent: 2002/0016339 (2002-02-01), Klein et al.
patent: 976722 (2000-02-01), None
patent: 0987274 (2000-03-01), None
patent: WO 92/06711 (1992-04-01), None
patent: WO 95/29189 (1995-11-01), None
patent: WO 96/04267 (1996-02-01), None
patent: WO 96/12800 (1996-05-01), None
patent: WO 97/28129 (1997-08-01), None
patent: WO 97/47651 (1997-12-01), None
patent: WO 99/48870 (1999-09-01), None
patent: WO 01/19788 (2001-03-01), None
Honna et al. “1-N-amidino . . . ” CA 91:193292 (1979).
Kawamoto et al. “Preparation of 2-(2-carbamoyl-4-pyrrolidinylthiocarbapenems as antibiotics” CA 120:269926 (1994).
Andereson et al. “Nonpeptide GnRH agents . . . ” CA 132:279106 (2000).
Levesque et al. “Novel bicyclic lactam inhibitors of thrombin . . . ” CA 136:210039 (2001).
Ackerman et al. “Preparation of amidino . . . ” CA 116:214908 (1992).
Hendrix et al. “Preparation of heterocyclic . . . ” CA 137:201331 (2002).
Rubini et al. “Synthesis of isosteric . . . ” Tetrahedron v.42 p. 6039-45 (1986).
King “Bioisosteres, conformational . . . ” Med. Che. Principle and Practice (1994) p. 206-208.
Adang Anton E P et al., A New Generation of Orally Active Antithrombotics: Comparing Strategies in the GBIIb/Illa, Thrombin and Factor Xa Areas, Drugs of the Future 2000; vol. 25(4); pp. 369-383.
Bundgaard, Hans, Novel Chemical Approaches in Prodrug Design, Drugs of the Future, (1991), vol. 16, No. 5, pp. 443-458.
Carpino,L., 1-Hydroxy-7-Azabenzotriazole. An Efficient Peptide Coupling Additive, J.Am. Chem. Soc. 1993, vol. 115, pp. 4397-4398.
Cheng Yung-Chi et al., Relationship Between the Inhibition Constant (K1) and the Concentration of Inhibitor which causes 50 per cent Inhibition (I 50) of an Enzymatic Reaction, Biochem. Pharmacol., 1973, vol. 22, pp. 3099-3108.
Fleisher David et al., Improved Oral Drug Delivery: Solubility Limitations Overcome by the Use of Prodrugs, Advanced Drug Delivery Reviews; 1996; vol. 19; pp. 115-130.
Giralt,E., Peptides 1990, Proceedings of the Twenty-First European Peptide Symposium Sep. 2-8, 1990, Platja d'Aro, Spain pp. 143-145, 1991.
Ostrem James A et al., Discovery of a Novel, Potent, and Specific Family of Factor Xa Inhibitors via Combinatorial Chemistry, Biochemistry, 1998, vol. 37, pp. 1053-1059.
Segel Irwin H, Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, Enzyme Kinetics, 1975, John Wiley & Sons, New York, pp. 100-125.

Affiliated with

Also associated with

Rating

Guanidine and amidine derivatives as factor Xa inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Guanidine and amidine derivatives as factor Xa inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guanidine and amidine derivatives as factor Xa inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3992256